Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
O'Neill Vincent
See Remarks at BioXcel Therapeutics. Filing since 28 Dec 2020.
CIK 0001672718
Company
Date
Role
Action
Shares
Amount
Of holding
BTAI
BioXcel Therapeutics, Inc.
16 Dec 2024
See Remarks
Sold on a plan
165
$58.13
0.8%
BTAI
BioXcel Therapeutics, Inc.
3 Oct 2024
See Remarks
Sold on a plan
5,556
$3.06K
22.1%
BTAI
BioXcel Therapeutics, Inc.
16 Sep 2024
See Remarks
Sold on a plan
138
$95.33
3.4%
BTAI
BioXcel Therapeutics, Inc.
17 Jun 2024
See Remarks
Sold on a plan
155
$199.18
4.2%
BTAI
BioXcel Therapeutics, Inc.
4 Apr 2024
See Remarks
Sold on a plan
165
$432.48
3.0%
BTAI
BioXcel Therapeutics, Inc.
15 Mar 2023
Chief Medical Officer
Sold, plan not stated
845
$16.64K
40.5%
BTAI
BioXcel Therapeutics, Inc.
20 Jan 2023
Chief Medical Officer
Sold, plan not stated
29,713
$891.39K
100%
BTAI
BioXcel Therapeutics, Inc.
17 Feb 2021
Chief Medical Officer
Sold, plan not stated
25,000
$1.39M
100%
BTAI
BioXcel Therapeutics, Inc.
19 Jan 2021
Chief Medical Officer
Sold, plan not stated
25,000
$1.24M
100%
BTAI
BioXcel Therapeutics, Inc.
28 Dec 2020
Chief Medical Officer
Sold, plan not stated
25,000
$1.29M
100%
10 decisions on file.
